High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
Paediatrics
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial
Paediatrics

High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children’s Oncology Group AALL1231 trial

Haematologica. 2025 Jan 30. doi: 10.3324/haematol.2024.286171. Online ahead of print.

ABSTRACT

Not available.

PMID:39882653 | DOI:10.3324/haematol.2024.286171